Stimulant treatment in children with ADHD can lead to serious adverse events, including psychosis and mania, particularly in those with comorbid BPD. Children with BPD exposed to stimulants experience ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared the use of NeuroSigma’s second-generation Monarch eTNS System for treating pediatric ADHD. The ...

ADHD is often treated with medications and behavioral therapy. Stimulants are first-choice medications for children with ADHD. ADHD symptoms in children can include inattention, hyperactivity, and ...

Please provide your email address to receive an email when new articles are posted on . Asian, Black and Hispanic children with ADHD were less likely to be prescribed medication early vs. white ...

LITTLETON, Colo., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (VVOS), a leading medical device and technology company specializing in the development and commercialization of highly ...

Researchers recently examined the records of patients ≥3 years old from multiple countries who had initiated pharmacotherapy for ADHD between 2010 and 2020. Children, adolescents, young adults, and ...

As cases of ADHD continue to rise among U.S. children, pediatricians at busy community practices are getting a much-needed assist from a web-based technology to improve the quality of ADHD care and ...

7 million kids from ages 3 to 17 have been diagnosed with ADHD at some point. Diagnoses of children with attention-deficit/hyperactivity disorder (ADHD) have surged ...

Co-occurring sleep problems in children with ADHD have been shown to predict more severe core symptoms, exacerbate daytime sleepiness, and reduce quality of life in both patients and caregivers.